ArticleBMC medical informatics and decision making2026
Research on the generalization of a blood donor recruitment framework based on machine learning.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTraditional short message service (SMS) recruitment, an essential method for recruiting blood donors, constitutes a highly imbalanced classification problem and still requires improvement in terms of efficiency and cost-effectiveness.
methodsUsing 513,523 donations and 11,616 SMS data from Nanjing, China, several machine learning models—including eXtreme Gradient Boosting (XGBoost), Support Vector Machine (SVM), K-Nearest Neighbors (KNN), Logistic Regression (LR), Decision Tree (DT), Random Forest (RF), and Multi-Layer Perceptron (MLP)—were initially trained, followed by an incremental learning strategy and a dynamic threshold adjustment mechanism, sampling techniques such as Synthetic Minority Oversampling Technique (SMOTE) and under-sampling (US) were employed, in combination with cost-sensitive learning approaches, including Minimum Feasibility Error (MFE), Minimum Feasibility Error (MSFE), and weighted mean squared error loss functions. Then, by prioritizing recall as the core evaluation metric (supplemented by other indicators), the 2 models with the best performance were selected and fine-tuned with 10% of data from Suzhou and Yangzhou, China. Finally, a prospective study using a machine learning-based recruitment framework was conducted in 3 cities and its performance was compared with traditional recruitment methods.
results72 for MLP and 0.70 for RF. The fine-tuned models demonstrated good generalizability, achieving recall rates of 0.63 and 0.67 in Suzhou, and 0.58 and 0.63 in Yangzhou, respectively. Further optimization led to improved recall rates of 0 .70 and 0.77 in Suzhou, and 0.68 and 0.64 in Yangzhou. In prospective validations across 13 recruitment rounds in 3 cities, the ML-driven approach significantly outperformed conventional methods. It increased the recruitment success rate for high-willingness donors by an average of 151.57% (up to 408.28% in Nanjing) while recruitment efficiency increased by an average of 96.52% (up to 138.75% in Yangzhou). Consequently, recruitment efficiency per SMS improved by an average of 34.42% (up to 53.61% in Suzhou).
conclusionsThis study underscores and validates the effectiveness and generalizability of machine learning in enabling precise blood donor recruitment. The ML–driven recruitment framework exhibits strong reproducibility and replicability, which highlight its potential for broad deployment across diverse settings and offers a practical, cost-effective strategy to enhance blood supply stability. This data-driven approach represents a meaningful advancement in the modernization of blood services in China and holds important implications for improving donor engagement, ensuring the safety and stability of the blood supply, thereby promoting a more efficient and sustainable approach to maintaining a stable blood supply. CLINICAL TRIAL NUMBER: Not applicable
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.